GenomicsArteriosclerosis Thrombosis and Vascular BiologyPeer-reviewed
Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes
Madelynn N. Whittaker, Lauren C. Testa, Aidan Quigley…·Xiao Wang
This study evaluates the durability of epigenome editing for reducing gene expression in cardiovascular disease targets, finding durable effects for PCSK9 but not for ANGPTL3 or AGT.
19 citations